High-level inducible Smad4-reexpression in the cervical cancer cell line C4-II is associated with a gene expression profile that predicts a preferential role of Smad4 in extracellular matrix composition
2007

Smad4's Role in Cervical Cancer and Extracellular Matrix Composition

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Klein-Scory Susanne, Zapatka Marc, Eilert-Micus Christina, Hoppe Sabine, Schwarz Elisabeth, Schmiegel Wolff, Hahn Stephan A, Schwarte-Waldhoff Irmgard

Primary Institution: University of Bochum, Bochum, Germany

Hypothesis

The study investigates the role of Smad4 reexpression in cervical cancer cells and its impact on tumor suppression and gene expression.

Conclusion

Smad4-mediated tumor suppression in cervical cancer cells is linked to extracellular matrix interactions rather than TGF-β growth inhibitory responses.

Supporting Evidence

  • Smad4 reexpression was shown to reduce tumor growth in vivo.
  • Induction of extracellular matrix-associated genes was observed in response to Smad4 reexpression.
  • Physiological levels of Smad4 were sufficient to mediate tumor suppression.
  • Classical TGF-β target genes were not induced by Smad4 reexpression.

Takeaway

Researchers found that a protein called Smad4 can help fight cervical cancer by changing how cancer cells interact with their surroundings, not just by stopping their growth.

Methodology

The study used Smad4-deficient C4-II cervical carcinoma cells to establish inducible Smad4 reexpression and analyzed its effects on cell growth and gene expression.

Limitations

The study may not fully capture the complexity of Smad4's role in vivo due to the controlled experimental conditions.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-7-209

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication